Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Matthew Rausch, Jing Hua, Devapregasan Moodley, Kerry F. White, Katherine H. Walsh, Christine E. Miller, Gege Tan, Benjamin H. Lee, Isabelle Cousineau, Jean-Baptiste Lattouf, John Stagg, Vito J. Palombella, Pamela M. Holland, Jonathan A. Hill | ||||||||||||
Title | Increased IL-27 is associated with poor prognosis in renal cell carcinoma and supports use of SRF388, a first-in-class IL-27p28 blocking antibody, to counteract IL-27-mediated immunosuppression in this setting | ||||||||||||
|
|||||||||||||
URL | https://www.abstractsonline.com/pp8/#!/9045/presentation/7700 | ||||||||||||
Abstract Text | AACR 2020, Therapeutic Antibodies 3; PO.IM02.25, Abs nr: 4550/18 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|